Transcatheter Embolization and Occlusion Devices Market by 2022
The Transcatheter Embolization and Occlusion Devices market is expected to be around US$ 6 Billion by 2028; Growing at a CAGR of more than 7.5% in the given forecast period.
Transcatheter embolization and occlusion (TEO) is a minimally invasive (MI) procedure performed in interventional radiology wherein an artificial embolus is placed or inserted through a fine catheter within the vessel to obstruct the blood flow towards tumour or specific area of the body. Coils are permanent embolic agents which are available a spread of shapes and sizes and are coated with chemotherapeutic drugs that block the blood supply also as induce cytotoxicity to attack the tumour.
Particulate agents like polyvinyl alcohol (PVA) and gelatine-impregnated acrylic polymer spheres are suspended in liquid and injected into the bloodstream to dam small blood vessels. This procedure is employed to stop abnormal bleeding, eliminate abnormal connections between arteries and veins, and to treat the aneurysm. Few of the main factors driving the market development are rising burden of targeted diseases, technological advances within the devices with enhanced efficiency, changing shift from clipping to coiling, rising preference for minimally invasive surgeries (MISs), and increasing adoption of TEO devices. Venous malformations are the foremost common of all vascular anomalies.
The global Transcatheter Embolization and Occlusion Devices market is segregated on the basis of Product as Coiled Devices and Non-Coiled Devices. Based on Indication the global Transcatheter Embolization and Occlusion Devices market is segmented in Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others. Based on End Users the global Transcatheter Embolization and Occlusion Devices market is segmented in Hospitals and Clinics, Ambulatory Surgery Centers (ASCs), and Others.
The global Transcatheter Embolization and Occlusion Devices market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Transcatheter Embolization and Occlusion Devices market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, Pfizer Inc., Cardinal Health, DePuy Synthes, Cook Medical, Sirtex Medical Limited, BTG plc, and others are among the major players in the global Transcatheter Embolization and Occlusion Devices market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Transcatheter Embolization and Occlusion Devices Market has been segmented as below:
Transcatheter Embolization and Occlusion Devices Market, By Product
Coiled Devices
Pushable Coils
Detachable Coils
Non-Coiled Devices
Flow-Diverting Devices
Embolization Particles
Liquid Embolic
Other Embolization and Occlusion Devices
Accessories
Transcatheter Embolization and Occlusion Devices Market, By Indication
Peripheral Vascular Disease
Oncology
Neurology
Urology
Others
Transcatheter Embolization and Occlusion Devices Market, By End Users
Hospitals and Clinics
Ambulatory Surgery Centers (ASCs)
Others
Transcatheter Embolization and Occlusion Devices Market, By Region
North America
Europe
Asia-Pacific
Rest of the World
Transcatheter Embolization and Occlusion Devices Market, By Company
Medtronic plc
Stryker Corporation
Terumo Corporation
Boston Scientific Corporation
Pfizer Inc.
Cardinal Health
DePuy Synthes
Cook Medical
Sirtex Medical Limited
BTG plc
Penumbra, Inc.
Edwards Lifesciences Corporation
Merit Medical Systems
Johnson & Johnson Services, Inc.
Abbott Laboratories.
The report covers:
Global Transcatheter Embolization and Occlusion Devices market sizes from 2021 to 2028, along with CAGR for 2023-2028
Market size comparison for 2022 vs 2028 with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
Global Transcatheter Embolization and Occlusion Devices market trends, covering comprehensive range of consumer trends & manufacturer trends
Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Transcatheter Embolization and Occlusion Devices market
Major market opportunities and challenges in forecast timeframe to be focused
Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
Comprehensive company profiles of the key industry players
Request Sample Report from here: https://www.marketresearchengine.com/transcatheter-embolization-and-occlusion-devices-market-report
Report Scope:
The global Transcatheter Embolization and Occlusion Devices market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Transcatheter Embolization and Occlusion Devices market share. Major industry players with significant revenue share include Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, Pfizer Inc., Cardinal Health, DePuy Synthes, Cook Medical, Sirtex Medical Limited, BTG plc, and others.
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com
Appreciate the creator